申请人:Li Jianqi
公开号:US20140221431A1
公开(公告)日:2014-08-07
Disclosed in the present invention is a novel histone deacetylase inhibitor of benzamides and use thereof. The inhibitor has good efficacy in treating diseases caused by abnormal gene expression, such as tumours, endocrine disorders, immune system diseases, genetic diseases and nerve system diseases. The histone deacetylase inhibitor of benzamides is a compound of the following general chemical structural formula (I) or a salt thereof.
本发明揭示了一种新型苯甲酰胺组的组蛋白去乙酰化酶抑制剂及其使用。该抑制剂在治疗由异常基因表达引起的疾病方面具有良好的疗效,如肿瘤、内分泌紊乱、免疫系统疾病、遗传疾病和神经系统疾病。苯甲酰胺组的组蛋白去乙酰化酶抑制剂是以下一般化学结构式(I)的化合物或其盐。